SABCS 2015: Less Treatment Is More for Early-stage Breast Cancer
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
Studies presented at this year’s San Antonio Breast Cancer Symposium shed light on new investigational therapies for patients with...
Guest Post by Kent Osborne, MD Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine;...
Carlos L. Arteaga, MD, past-president of the AACR, has been selected to receive the 2015 Prize for Scientific Excellence...
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at...
Jamie Holloway, a breast cancer researcher turned breast cancer patient and AACR Scientist↔Survivor Program advocate, started a blog to...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...